Heparin reacts with and inactivates nitric oxide

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 6, Issue 2, 2001, Pages 163-173

  Upchurch Jr , Gilbert R ^a,b   Goodman, Dorinda G ^a   Willoughby, Scott R ^a   Zhang, Ying Yi ^a   Welch, George N ^a   Freedman, Jane E ^a   Ye, Song ^a   Costello, Catherine E ^a   Loscalzo, Joseph ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Disaccharides; Heparin; Mass spectrometry; Nitric oxide

Indexed keywords

DISACCHARIDE; HEPARIN; NITRIC OXIDE; NITRITE; S NITROSOGLUTATHIONE;

ANTICOAGULATION; ARTICLE; CELL PH; DOSE RESPONSE; HUMAN; MASS SPECTROMETRY; NITROSATION; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTOPENIA; THROMBOGENESIS; ULTRAVIOLET SPECTROSCOPY;

EID: 0034758355     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/107424840100600208     Document Type: Article

References (31)

1. Heparin: What is it? How does it work?
2. Predictors of excessive blood use after coronary artery bypass grafting. A multivariate analysis
3. Heparin-induced thrombocytopenia: Mechanism of interaction of the heparin-dependent antibody with platelets
4. Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass
5. Effects of unfractionated and low molecular weight heparins on platelet thromboxane, biosynthesis in vivo
6. Protective role of heparin on in vitro functional aortic response in Watanabe heritable hyperlipidemic rabbits
7. Heparin prevents postischemic endothelial cell dysfunction by a mechanism independent of its anticoagulant activity
8. High-dose heparin decreases nitric oxide production by cultured bovine endothelial cells
9. Inhibition of the heparin effect by nitroglycerin
10. Propylene glycol-induced heparin resistance during nitroglycerin infusion
11. Heparin-resistance induced by intravenous nitroglycerin. A word of caution when both drugs are used concomitantly
12. Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols
13. Impaired EDRF production by endothelial cells exposed to fibrin monomer and FDP
14. A scheme for the colorimetric determination of microgram amounts of thiols
15. Biochemistry of nitric oxide and its redox-activated forms
16. Control of coronary vascular tone by nitric oxide
17. Nitric oxide release accounts for the biologic activity of endothelium-derived relaxing factor
18. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide
19. The obligatory role of endothelial cells in relaxation of arterial smooth muscle by acetylcholine
20. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein
21. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: Evidence for the involvement of S-nitrosothiols as active intermediates
22. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin
23. NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties
24. In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols
25. S-transnitrosation reactions are involved in the metabolic fate and biological actions of nitric oxide
26. Cell-surface protein disulfide isomerase catalyzes transnitrosation and regulates intracellular transfer of nitric oxide
27. Nitrosation of tryptophan residue(s) in serum albumin and model dipeptides. Biochemical characterization and bioactivity
28. Chemistry and biology of nitrosated peptides
29. The heparin target organ - The endothelium. Studies in a rat model
30. Causes of primary graft failure after in situ saphenous vein bypass grafting
31. Coronary restenosis: What have we learned from angiography?